Testing effectiveness (Phase 2)UnknownNCT00979160What this trial is testingEvaluation of Response of Dasatinib to Treat MastocytosisWho this might be right forSystemic Mastocytosis Federico II University 30
Not applicableLooking for participantsNCT06501781What this trial is testingPeer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)Who this might be right forHIV InfectionsSubstance Use University of Maryland, Baltimore 186
Not applicableEnded earlyNCT02818283What this trial is testingSoy Modulation of Immune Activation, LDL- Levels, and Lowering Inflammation by Pretzel Isoflavone Dietary InterventionWho this might be right forHuman Immunodeficiency Virus (HIV) InfectionHypercholesterolemia Ohio State University 1
Testing effectiveness (Phase 2)Study completedNCT00171912What this trial is testingImatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase EnzymesWho this might be right forHypereosinophilic SyndromeSystemic MastocytosisChronic Myelomonocytic Leukemia+1 more Novartis Pharmaceuticals 38
Testing effectiveness (Phase 2)Study completedNCT03526250What this trial is testingPalbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more National Cancer Institute (NCI) 23
Not applicableActive Not RecruitingNCT03182491What this trial is testingMechanisms of AnaphylaxisWho this might be right forAnaphylaxisAllergyTransfusion Reaction+1 more Haukeland University Hospital 40
Not applicableEnded earlyNCT01322555What this trial is testingThe Association Between Autism and Immune Changes in the BrainWho this might be right forAutism Spectrum DisordersBrain DiseaseAutism+1 more National Institute of Mental Health (NIMH) 15
Testing effectiveness (Phase 2)Study completedNCT01299948What this trial is testingProgression of HIV-Disease Under Low Dose CorticosteroidsWho this might be right forHIV Disease Progression Medical Mission Institute, Germany 326
Not applicableLooking for participantsNCT04174755What this trial is testingSemaglutide's Efficacy in Achieving Weight Loss for Those With HIVWho this might be right forObesityHIV-1-infection University College Dublin 80
Not applicableStudy completedNCT04359368What this trial is testingCharacteristics of Patients With Hypersensitivity Reactions to Intravenous Iron InfusionsWho this might be right forIron-deficiencyHypersensitivity Reactions University Hospital, Basel, Switzerland 42
Large-scale testing (Phase 3)Study completedNCT02448381What this trial is testingFLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)Who this might be right forCutaneous T-Cell Lymphoma Soligenix 169
Not applicableStudy completedNCT00890435What this trial is testingDecision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialWho this might be right forBrain and Central Nervous System TumorsLeukemiaUnspecified Adult Solid Tumor, Protocol Specific+1 more Children's Oncology Group 53
Early research (Phase 1)Study completedNCT03158935What this trial is testingThe ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) TrialWho this might be right forAdvanced Ovarian CancerMalignant Melanoma University Health Network, Toronto 8
Not applicableStudy completedNCT03483389What this trial is testingAlcohol and Immune ResponseWho this might be right forAlcohol DrinkingAlcohol; Harmful Use Brown University 76
Testing effectiveness (Phase 2)UnknownNCT01067417What this trial is testingEvaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected PatientsWho this might be right forHIV Infections Medical Research Council 83
Large-scale testing (Phase 3)Study completedNCT03403569What this trial is testingSafety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 InfectionWho this might be right forHIV-infection/AIDS Peking Union Medical College Hospital 353
Not applicableUnknownNCT06013683What this trial is testingA Registry for Patients With Systemic Mastocytosis in ChinaWho this might be right forSystemic Mastocytoses The First Affiliated Hospital of Soochow University 150
Testing effectiveness (Phase 2)Study completedNCT02706717What this trial is testingEffects of the Probiotic Visbiome Extra Strength on Gut Microbiome & Immune Activation MarkersWho this might be right forHIV-1 Infection Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 93
Testing effectiveness (Phase 2)Study completedNCT01543958What this trial is testingSevelamer for Reducing Endotoxemia and Immune ActivationWho this might be right forHIV-1 Infection Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 40
Early research (Phase 1)Active Not RecruitingNCT06325748What this trial is testingSENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDSWho this might be right forAML/MDSCD33 Expressing Hematological MalignanciesFLT3 Expressing Hematological Malignancies Senti Biosciences 21